Outcome of two patients harboring EML4-ALK fusion gene with brain metastasis treated with crizotinib

被引：0
|
作者：
Okimoto, Tamio [1 ]
Tsubata, Yukari [1 ]
Nakao, Mika [1 ]
Koba, Naoya [1 ]
Hotta, Takamasa [1 ]
Hamaguchi, Megumi [1 ]
Hamaguchi, Shunnichi [1 ]
Sutani, Akihisa [1 ]
Hamada, Akinobu [2 ]
Isobe, Takeshi [1 ]
机构：
[1] Shimane Univ, Sch Med, Dept Internal Med, Div Clin Oncol & Resp Med, Matsue, Shimane, Japan
[2] Natl Canc Ctr, Res Inst, Ctr Translat Res Core, Dept Clin Pharmacol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-1-56
引用
下载
收藏
页码：137 / 138
页数：2
相关论文
共 50 条
  • [41] The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma
    Heriyanto, Didik S.
    Trisnawati, Ika
    Kumara, Evan G.
    Laiman, Vincent
    Yuliani, Fara S.
    Sumpono, Auliya S. B.
    Cempaka, Rita
    Marcellus
    Budiono, Eko
    PULMONARY MEDICINE, 2020, 2020
  • [42] An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma
    Misove, Adela
    Vicha, Ales
    Zapotocky, Michal
    Malis, Josef
    Balko, Jan
    Nemeckova, Tereza
    Szabova, Jana
    Kyncl, Martin
    Novakova-Kodetova, Daniela
    Stolova, Lucie
    Jencova, Pavla
    Broz, Petr
    Krskova, Lenka
    GENES CHROMOSOMES & CANCER, 2021, 60 (12): : 837 - 840
  • [43] ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
    Guan, Jikui
    Chuang, Tzu-Po
    Vikstrom, Anders
    Palmer, Ruth H.
    Hallberg, Bengt
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [44] Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
    Aydemirli, Mehtap Derya
    van Eendenburg, Jaap D. H.
    van Wezel, Tom
    Oosting, Jan
    Corver, Willem E.
    Kapiteijn, Ellen
    Morreau, Hans
    ENDOCRINE-RELATED CANCER, 2021, 28 (06) : 377 - 389
  • [45] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [46] Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion
    Aguado, Cristina
    Gil, Maria-de-los-Llanos
    Yeste, Zaira
    Gimenez-Capitan, Ana
    Teixido, Cristina
    Karachaliou, Niki
    Viteri, Santiago
    Rosell, Rafael
    Molina-Vila, Miguel A.
    ONCOTARGETS AND THERAPY, 2018, 11 : 1117 - 1120
  • [47] Clinicopathologic Features of Patients with Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Gene: A Meta-Analysis
    Wang, Ying
    Wang, Shumin
    Xu, Shiguang
    Qu, Jiaqi
    Liu, Bo
    PLOS ONE, 2014, 9 (10):
  • [48] Coexistence of a Novel PRKCB-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient and Response to Crizotinib
    Luo, Jing
    Gu, Dejian
    Lu, Huasong
    Liu, Si
    Kong, Jinliang
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : E266 - E268
  • [49] An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene
    Toyokawa, Gouji
    Takenoyama, Mitsuhiro
    Taguchi, Kenichi
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Shiraishi, Yoshimasa
    Morodomi, Yosuke
    Takenaka, Tomoyoshi
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Seto, Takashi
    Shimokawa, Mototsugu
    Ichinose, Yukito
    LUNG CANCER, 2013, 81 (03) : 487 - 490
  • [50] Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?
    Antoniu, Sabina Antonela
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) : 351 - 353
12345